Department of Endocrinology, The First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, Shaanxi, China.
Med-X Institute, Center for Immunological and Metabolic Diseases, The First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, Shaanxi, China.
Front Endocrinol (Lausanne). 2024 Jan 15;14:1337469. doi: 10.3389/fendo.2023.1337469. eCollection 2023.
BACKGROUND: Diabetic nephropathy (DN) is one of the most prevalent and severe microvascular complications of type 2 diabetes (T2DM). However, little is currently known about the pathogenesis and its associated risk factors in DN. The present study aims to investigate the potential risk factors of DN in patients with T2DM. METHODS: A total of 6,993 T2DM patients, including 5,089 participants with DN and 1,904 without DN, were included in this cross-sectional study. Comparisons between the two groups (DN vs. non-DN) were carried out using Student's t-test, Mann-Whitney U-test, or Pearson's Chi-squared test. Spearman's correlation analyses were performed to assess the correlations of serum lipids and indicators of renal impairment. Logistic regression models were applied to assess the relationship between blood lipid indices and the presence of DN. RESULTS: T2DM patients with DN were older, and had a longer duration of diagnosed diabetes compared to those without DN. Of note, the DN patients also more likely develop metabolic disorders. Among all serum lipids, Lipoprotein(a) [Lp(a)] was the most significantly correlated indicators of renal impairment. Moreover, univariate logistic regression showed that elevated Lp(a) level was associated with an increased risk of DN. After adjusted for confounding factors, including age, gender, duration of T2DM, BMI, SBP, DBP and lipid-lowering drugs usage, Lp(a) level was independently positively associated with the risk of DN [odds ratio (OR):1.115, 95% confidence interval (CI): 1.079-1.151, =6.06×10]. CONCLUSIONS: Overall, we demonstrated that serum Lp(a) level was significantly positively associated with an increased risk of DN, indicating that Lp(a) may have the potential as a promising target for the diagnosis and treatment of diabetic nephropathy.
背景:糖尿病肾病(DN)是 2 型糖尿病(T2DM)最常见和最严重的微血管并发症之一。然而,目前对于 DN 的发病机制及其相关危险因素知之甚少。本研究旨在探讨 T2DM 患者发生 DN 的潜在危险因素。
方法:本横断面研究共纳入 6993 例 T2DM 患者,其中 5089 例患者患有 DN,1904 例患者未患有 DN。采用 Student's t 检验、Mann-Whitney U 检验或 Pearson's Chi-squared 检验对两组(DN 与非 DN)进行比较。采用 Spearman 相关分析评估血清脂质和肾功能损害指标之间的相关性。采用 logistic 回归模型评估血脂指标与 DN 发生的关系。
结果:与非 DN 患者相比,DN 患者年龄更大,确诊糖尿病的病程更长。值得注意的是,DN 患者更易发生代谢紊乱。在所有血清脂质中,脂蛋白(a)[Lp(a)]与肾功能损害的相关性最显著。此外,单因素 logistic 回归显示,Lp(a)水平升高与 DN 的发生风险增加相关。在调整年龄、性别、T2DM 病程、BMI、SBP、DBP 和降脂药物使用等混杂因素后,Lp(a)水平与 DN 的发病风险呈独立正相关[比值比(OR):1.115,95%置信区间(CI):1.079-1.151,=6.06×10]。
结论:总体而言,我们发现血清 Lp(a)水平与 DN 的发生风险呈显著正相关,表明 Lp(a)可能成为诊断和治疗糖尿病肾病的有前途的靶点。
Front Endocrinol (Lausanne). 2023
Front Endocrinol (Lausanne). 2021
Diabetes Metab Syndr Obes. 2023-6-22
J Diabetes Complications. 2016-7
J Diabetes Complications. 2023-1
N Engl J Med. 2022-11-17
Front Endocrinol (Lausanne). 2021
Diabetes Care. 2021-1
Curr Diab Rep. 2019-3-2